
24-mg Tab: 48 mg divided over the day. (See Table 2.)

The dosage should be individually adapted according to the response. Improvement can sometimes only be observed after a couple of weeks of treatment. The best results are sometimes obtained after a few months. There are indications that treatment from the onset of the disease prevents the progression of the disease and/or the loss of hearing in later phases of the disease.
Pediatric: Serc is not recommended for use in children below18 years due to insufficient data on safety and efficacy.
Geriatric: Although there are limited data from clinical studies in this patient group, extensive post-marketing experience suggests that no dose adjustment is necessary in this patient population.
Renal and/or Hepatic Impairment: There are no specific clinical trials available in this patient groups, but according to the post-marketing experience, no dose adjustment appears to be necessary.
Administration: Should be swallowed with water.